I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.
We talk about:
Transitioning from clinical practice to med affairs
Changes in how other groups in pharma see med affairs
The differences between access and adoption (and how to impact both)
Advances in patient engagement and much more
A quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.
At one point I reference the MAPS, Future of Medical Affairs report. You can view the whole report here: https://medicalaffairs.org/future-medical-affairs-2030/
Share this post